Jennifer Beckman, MSN, ARNP, CHFN, AACC

Associate Director MCS l Nurse Practitioner of the HF Continuum | Researcher

[Jennifer Beckman, MSN, ARNP, CHFN, AACC @JenBeckmanARNP]

@JeffTeuteberg @PNWHeartFailure @UWCardiology @OHSUNews @kpwashington @ProvHealthNews @VMFHealth @WeAreConfluence @OverlakeHMC @UWSurgery @uwashfellows @Stanford_HF @tcccop @ParagonixSherpa @stanfordctsurg @StanfordMed @GautamNayakMD @KhorsandiMaziar @HFSA @ISHLT @ACCinTouch Dr. Teuteberg, so thankful you were able to join us and share your unique perspective on heart preservation!

[Jeff Teuteberg @JeffTeuteberg]

Many 🙏🏻for the opportunity to participate in @PNWHeartFailure‼️Fantastic faculty, engaging agenda and in a beautiful setting.
@UWCardiology @OHSUNews @kpwashington @ProvHealthNews @VMFHealth @WeAreConfluence @OverlakeHMC @JenBeckmanARNP @UWSurgery @uwashfellows

[PNW Heart Failure Conference @PNWHeartFailure]

Kudos to a full house of committed attendees still learning post-lunch day 2 on a beautiful Saturday here in Seattle.

[PNW Heart Failure Conference @PNWHeartFailure]

Turn out was great for the morning session focused on Acute Cariogenic Shock and “Initial Evaluation and Management of Cardiogenic Shock” with @PurohitSuneet from @ProvAK

[PNW Heart Failure Conference @PNWHeartFailure]

Next debate!

Pro and Cons of Substance Use Considerations for Advanced Therapies.

Amanda Thomas, B.S.N., RN, CHFN @OHSUCardio
Vs.
Jennifer Azen, MD @UWMedicine

[Jennifer Beckman, MSN, ARNP, CHFN, AACC @JenBeckmanARNP]

Excellent first day of @PNWHeartFailure conference! As course directors we’re thrilled to have a great turnout along with innovative presentations/discussions surrounding all things heart failure!

[PNW Heart Failure Conference @PNWHeartFailure]

Great turnout = happy + relieved course directors.

[Jennifer Beckman, MSN, ARNP, CHFN, AACC @JenBeckmanARNP]

Please join us this August for the Pacific Northwest Heart Failure Conference! We will discuss all aspects of heart failure care from experts in the field! Register at https://t.co/TiVxzEIMPq @UWMedHeart @uwashfellows @UWSoN

[UWashington Heart Institute @UWMedHeart]

Register today!

[UWashington Heart Institute @UWMedHeart]

Register today!

[Dr. Claudius Mahr, FACC, FESC, FRSM @DrClaudiusMahr]

DT VAD therapy is cost effective in the UK health system. @JenBeckmanARNP @WCL92689433 @Richardkcheng2 @UWMedHeart https://t.co/vo6iesVvQ5

[Jennifer Beckman, MSN, ARNP, CHFN, AACC @JenBeckmanARNP]

Looking forward to this conversation tomorrow. Please join us!

[Medtronic Cardiac @MDT_Cardiac]

Register now for a virtual advanced #heartfailure discussion at @AAHFN. Join @JenBeckmanARNP as she leads the conversation on #LVAD patient management and strategies. https://t.co/e2zjp7BLbY

[Jennifer Beckman, MSN, ARNP, CHFN, AACC @JenBeckmanARNP]

Honored to be speaking for the @AAHFN advanced heart failure symposium! Please join as we have a conversation surrounding caring for this patient population. @MDT_Cardiac

[G. Burkhard Mackensen @gb_mackensen]

Just finished a very successful Live case transmission of a MitraClip procedure with the G4 system from @UWMedHeart to the 2020 🇨🇳 China Structural Heart Disease Meeting. Great team effort of the @UWCathLab team staying late to get this accomplished. @ASE360 @Reismanmmd #iecho

[asaiojournal @asaiojournal]

Cost-Effectiveness of a Small Intrapericardial Centrifugal Left Ventricular Assist Device
https://t.co/Dkb1TVAUBl
@ssilvestryMD @DrClaudiusMahr

#LVAD #CostEffectiveness #BridgetoTransplant #DestinationTherapy

[Jennifer Beckman, MSN, ARNP, CHFN, AACC @JenBeckmanARNP]

Discussion regarding anticoagulation in #lvad patients after ischemic stroke. @DrClaudiusMahr @lisong2003 @cj_creutzfeldt

[asaiojournal @asaiojournal]

#FREE #OnlineFirst Acute #Anticoagulation After Ischemic Stroke in Patients With Left Ventricular Assist Devices
https://t.co/cjAOgZMSYB
@DrClaudiusMahr @JenBeckmanARNP @lisong2003 @cj_creutzfeldt

#LVAD #IschemicStroke #hemorrhage #thrombosis

[Dr. Claudius Mahr, FACC, FESC, FRSM @DrClaudiusMahr]

This is great news for our patients. Looking forward to collaborating with our amazing nephrology colleagues. @NishaKidneyDoc @narora216. We will keep you busy!

[asaiojournal @asaiojournal]

Effect of Blood Group on Heart Transplant Waitlist Mortality in the Ventricular Assist Device Era
https://t.co/gyNtqXUOBH
@UofLMedicine @LLUHealth

#HeartTx #BloodGroup #BloodType #VAD #TransplantWaitlist

[asaiojournal @asaiojournal]

#OnlineFirst Cost-Effectiveness of Thoracotomy Approach for the Implantation of a Centrifugal Left Ventricular Assist Device
https://t.co/nmfPqan3df
@DrClaudiusMahr @JenBeckmanARNP @ssilvestryMD

#LVAD #Thoracotomy #BridgeToTransplant #CostEffectiveness

[Dr. Claudius Mahr, FACC, FESC, FRSM @DrClaudiusMahr]

BTT VAD via thoracotomy is a cost effective bridge to transplantation strategy! @Richardkcheng2 @JenBeckmanARNP @WCL92689433 @ssilvestryMD @UWMedicine @UWMedHeart

[asaiojournal @asaiojournal]

ASAIO Journal 2019 Impact Factor is 2.678!

Sincere and enthusiastic thanks to our section editors, editorial board, reviewers, authors, and readers!